| Affiliation: | 1. Charité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Germany;2. Ghent University, Faculty of Medicine and Health Sciences, Belgium;3. University of Nebraska Medical Center, College of Nursing, Omaha, NE, USA;4. Silver Chain Group and Curtin University School of Nursing, Midwifery and Paramedicine, Perth, Australia;5. University of Lübeck, Nursing Research Unit, Germany;6. Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Hospital, Bedford, USA;7. Boston University School of Medicine MA, USA;8. Princess Margaret Hospital, Hong Kong;9. CASE Software & Books, Greensboro, USA;10. Christchurch Hospital, New Zealand;11. Royal College of Surgeons in Ireland, Dublin, Ireland;12. Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia;13. Department of Public Health, Faculty of Medicine and Health Sciences, UGent, Ghent University, Belgium;14. Lida Institute, Shanghai, China;15. Cardiff University, Cardiff, Wales, United Kingdom;p. Indiana University Health Academic Health Center, Indianapolis, IN, USA;q. National Scientific Research Center - University of Lyon 1, UMR, 5305, France;r. Laboratory of Tissue Biology and Therapeutic Engineering, Lyon, France;s. Singapore General Hospital, Singapore;t. Curtin University, School of Nursing, Midwifery and Paramedicine, Australia;u. LaTrobe University, Australian Centre for Evidence Based Aged Care, School of Nursing and Midwifery, Australia;v. Australian National University, ANU Medical School, Academic Unit of General Practice, Australia |
| Abstract: | AimThe European Pressure Ulcer Advisory Panel, the Pan Pacific Pressure Injury Alliance, and the National Pressure Ulcer Advisory Panel are updating the ‘Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline’ (CPG) in 2019. The aim of this contribution is to summarize and to discuss the guideline development protocol for the 2019 update.MethodsA guideline governance group determines and monitors all steps of the CPG development. An international survey of consumers will be undertaken to establish consumer needs and interests. Systematic evidence searches in relevant electronic databases cover the period from July 2013 through August 2018. Risk of bias of included studies will be assessed by two reviewers using established checklists and an overall strength of evidence assigned to the cumulative body of evidence. Small working groups review the evidence available for each topic, review and/or draft the guideline chapters and recommendations and/or good practice statements. Finally, strength of recommendation grades are assigned. The recommendations are rated based on their importance and their potential to improve individual patient outcomes using an international formal consensus process.DiscussionMajor methodological advantages of the current revision are a clear distinction between evidence-based recommendations and good practice statements and strong consumer involvement.ConclusionThe 2019 guideline update builds on the previous 2014 version to ensure consistency and comparability. Methodology changes will improve the guideline quality to increase clarity and to enhance implementation and compliance. The full guideline development protocol can be accessed from the guideline website ( http://www.internationalguideline.com/). |
